BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 16436655)

  • 21. Tauroursodeoxycholate inhibits human cholangiocarcinoma growth via Ca2+-, PKC-, and MAPK-dependent pathways.
    Alpini G; Kanno N; Phinizy JL; Glaser S; Francis H; Taffetani S; LeSage G
    Am J Physiol Gastrointest Liver Physiol; 2004 Jun; 286(6):G973-82. PubMed ID: 14701718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatoprotection in ethinylestradiol-treated rats is provided by tauroursodeoxycholic acid, but not by ursodeoxycholic acid.
    Azer SA; Canfield PJ; Stacey NH
    J Gastroenterol Hepatol; 1995; 10(3):261-9. PubMed ID: 7548801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. All-trans-retinoic acid improves cholestasis in α-naphthylisothiocyanate-treated rats and Mdr2-/- mice.
    Cai SY; Mennone A; Soroka CJ; Boyer JL
    J Pharmacol Exp Ther; 2014 Apr; 349(1):94-8. PubMed ID: 24492652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytoprotective effects of taurocholic acid feeding on the biliary tree after adrenergic denervation of the liver.
    Marzioni M; Ueno Y; Glaser S; Francis H; Benedetti A; Alvaro D; Venter J; Fava G; Alpini G
    Liver Int; 2007 May; 27(4):558-68. PubMed ID: 17403196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ursodeoxycholic acid shows antineoplastic effects in bile duct cancer cells via apoptosis induction; p53 activation; and EGFR-ERK, COX-2, and PI3K-AKT pathway inhibition.
    Lee J; Hong EM; Kim JH; Kim JH; Jung JH; Park SW; Koh DH; Jang HJ
    Mol Biol Rep; 2021 Sep; 48(9):6231-6240. PubMed ID: 34392440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells.
    He H; Mennone A; Boyer JL; Cai SY
    Hepatology; 2011 Feb; 53(2):548-57. PubMed ID: 21274875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intestinal absorption and biliary secretion of ursodeoxycholic acid and its taurine conjugate.
    Rudolph G; Kloeters-Plachky P; Sauer P; Stiehl A
    Eur J Clin Invest; 2002 Aug; 32(8):575-80. PubMed ID: 12190957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogens maintain bile duct mass and reduce apoptosis after biliodigestive anastomosis in bile duct ligated rats.
    Svegliati-Baroni G; Ghiselli R; Marzioni M; Alvaro D; Mocchegiani F; Saccomanno S; Sisti V; Ugili L; Orlando F; Alpini G; Saba V; Benedetti A
    J Hepatol; 2006 Jun; 44(6):1158-66. PubMed ID: 16481066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exendin-4, a glucagon-like peptide 1 receptor agonist, protects cholangiocytes from apoptosis.
    Marzioni M; Alpini G; Saccomanno S; Candelaresi C; Venter J; Rychlicki C; Fava G; Francis H; Trozzi L; Benedetti A
    Gut; 2009 Jul; 58(7):990-7. PubMed ID: 18829977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidative stress and apoptosis in fetal rat liver induced by maternal cholestasis. Protective effect of ursodeoxycholic acid.
    Perez MJ; Macias RI; Duran C; Monte MJ; Gonzalez-Buitrago JM; Marin JJ
    J Hepatol; 2005 Aug; 43(2):324-32. PubMed ID: 15970352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ursodeoxycholic acid but not tauroursodeoxycholic acid inhibits proliferation and differentiation of human subcutaneous adipocytes.
    Mališová L; Kováčová Z; Koc M; Kračmerová J; Stich V; Rossmeislová L
    PLoS One; 2013; 8(12):e82086. PubMed ID: 24312631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver.
    Benedetti A; Alvaro D; Bassotti C; Gigliozzi A; Ferretti G; La Rosa T; Di Sario A; Baiocchi L; Jezequel AM
    Hepatology; 1997 Jul; 26(1):9-21. PubMed ID: 9214446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of ursodeoxycholic acid on intracellular pH in a bile duct epithelium-like cell line.
    Strazzabosco M; Poci C; Spirlí C; Sartori L; Knuth A; Crepaldi G
    Hepatology; 1994 Jan; 19(1):145-54. PubMed ID: 8276351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholestasis, altered junctional permeability, and inverse changes in sinusoidal and biliary glutathione release by vasopressin and epinephrine.
    Ballatori N; Truong AT
    Mol Pharmacol; 1990 Jul; 38(1):64-71. PubMed ID: 2115113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid hormone inhibits biliary growth in bile duct-ligated rats by PLC/IP(3)/Ca(2+)-dependent downregulation of SRC/ERK1/2.
    Fava G; Ueno Y; Glaser S; Francis H; Demorrow S; Marucci L; Marzioni M; Benedetti A; Venter J; Vaculin B; Vaculin S; Alpini G
    Am J Physiol Cell Physiol; 2007 Apr; 292(4):C1467-75. PubMed ID: 17192280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice.
    Van den Bossche L; Hindryckx P; Devisscher L; Devriese S; Van Welden S; Holvoet T; Vilchez-Vargas R; Vital M; Pieper DH; Vanden Bussche J; Vanhaecke L; Van de Wiele T; De Vos M; Laukens D
    Appl Environ Microbiol; 2017 Apr; 83(7):. PubMed ID: 28115375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited.
    Paumgartner G; Beuers U
    Hepatology; 2002 Sep; 36(3):525-31. PubMed ID: 12198643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Administration of tauroursodeoxycholic acid (TUDCA) reduces apoptosis following myocardial infarction in rat.
    Rivard AL; Steer CJ; Kren BT; Rodrigues CM; Castro RE; Bianco RW; Low WC
    Am J Chin Med; 2007; 35(2):279-95. PubMed ID: 17436368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histamine stimulates the proliferation of small and large cholangiocytes by activation of both IP3/Ca2+ and cAMP-dependent signaling mechanisms.
    Francis HL; Demorrow S; Franchitto A; Venter JK; Mancinelli RA; White MA; Meng F; Ueno Y; Carpino G; Renzi A; Baker KK; Shine HE; Francis TC; Gaudio E; Alpini GD; Onori P
    Lab Invest; 2012 Feb; 92(2):282-94. PubMed ID: 22064319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity.
    Buryova H; Chalupsky K; Zbodakova O; Kanchev I; Jirouskova M; Gregor M; Sedlacek R
    BMC Gastroenterol; 2013 Oct; 13():155. PubMed ID: 24172289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.